<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.17694.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Note</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Cadmium SAD phasing at CuK&#x03b1; wavelength</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 2 approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Eliseev</surname>
                        <given-names>Igor E.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-3344-2513</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Yudenko</surname>
                        <given-names>Anna N.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ukrainskaya</surname>
                        <given-names>Valeria M.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Chakchir</surname>
                        <given-names>Oleg B.</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>St. Petersburg National Research Academic University RAS, St. Petersburg, 194021, Russian Federation</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:eliseevie@gmail.com">eliseevie@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>21</day>
                <month>1</month>
                <year>2019</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2019</year>
            </pub-date>
            <volume>8</volume>
            <elocation-id>84</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>8</day>
                    <month>1</month>
                    <year>2019</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Eliseev IE et al.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/8-84/pdf"/>
            <abstract>
                <p>Single-wavelength anomalous diffraction (SAD) is the most common method for 
                    <italic toggle="yes">de novo</italic> elucidation of macromolecular structures by X-ray crystallography. It requires an anomalous scatterer in a crystal to calculate phases. A recent study by Panneerselvam 
                    <italic toggle="yes">et al</italic>. emphasized the utility of cadmium ions for SAD phasing at the standard synchrotron wavelength of 1 &#x00c5;. Here we show that cadmium is also useful for phasing of crystals collected in-house with CuK&#x03b1; radiation. Using a crystal of single-domain antibody as an experimental model, we demonstrate how cadmium SAD can be conveniently employed to solve a CuK&#x03b1; dataset. We then discuss the factors which make this method generally applicable.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Protein crystallography</kwd>
                <kwd>experimental phasing</kwd>
                <kwd>single-wavelength anomalous diffraction</kwd>
                <kwd>cadmium ions</kwd>
                <kwd>Cd-SAD</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>CJSC Biocad</funding-source>
                </award-group>
                <award-group id="fund-2">
                    <funding-source>Ministry of Science and Higher Education of the Russian Federation</funding-source>
                    <award-id>RFMEFI57716X0217</award-id>
                </award-group>
                <funding-statement>This work is funded by the Ministry of Science and Higher Education of the Russian Federation (contract 14.577.21.0217, unique identifier RFMEFI57716X0217) and co-funded by CJSC Biocad.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <p>Elucidation of atomic structures of macromolecules by X-ray crystallography requires knowledge of the phases of measured reflections. Nowadays this phase problem is most often solved by molecular replacement (MR), a computational technique which utilizes the known structure of a homologous molecule to estimate phases. However, in the case of 
                <italic toggle="yes">de novo</italic> structure elucidation when an appropriate homologous structure is unavailable, phases should be determined experimentally. This is predominantly achieved by analyzing anomalous scattering produced either by atoms naturally occurring in the molecule, or intentionally introduced into crystal during growth or soaking. The two phasing methods exploiting the anomalous scattering, multiwavelength anomalous diffraction (MAD) and single-wavelength anomalous diffraction (SAD), were reviewed by Hendrickson
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. Synchrotron radiation with tunable wavelength allows achieving the absorption edges of all elements with Z&#x2265;20 to maximize anomalous signal, thus making these methods remarkably versatile.</p>
            <p>On the contrary, the choice of anomalous scatterer is minimal when data are to be collected in-house using a laboratory X-ray generator, most often equipped with a copper anode (&#x03bb;=1.5418 &#x212b;, CuK&#x03b1;). Indeed, in some cases, even weak anomalous signal of sulfur (
                <italic toggle="yes">f&#x2032;&#x2032;</italic>=0.56e
                <sup>-</sup> at CuK&#x03b1;) can be used for phasing, as demonstrated in pioneering SAD work on crambin
                <sup>
                    <xref ref-type="bibr" rid="ref-2">2</xref>
                </sup>. Similarly, zinc (
                <italic toggle="yes">f&#x2032;&#x2032;</italic>=0.68e
                <sup>-</sup> at CuK&#x03b1;) was proposed to be useful for in-house SAD experiments
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. Perhaps the most impressive result came from the structural genomics project, where iodine ion soaks were systematically used for 
                <italic toggle="yes">de novo</italic> SAD phasing of datasets collected with CuK&#x03b1; radiation
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>
                </sup>. Iodine has a strong anomalous scattering (
                <italic toggle="yes">f&#x2032;&#x2032;</italic>=6.9e
                <sup>-</sup> at CuK&#x03b1;), high solubility, and binds multiple hydrophobic sites or positively charged residues on protein surface. Iodine SAD appeared remarkably efficient for phasing the crystals of membrane proteins which possess patches of positively charged residues at the hydrophobic-hydrophilic interface, providing many binding sites for anions
                <sup>
                    <xref ref-type="bibr" rid="ref-5">5</xref>
                </sup>.</p>
            <p>Another attractive opportunity is to use cadmium ions, which have a great anomalous signal (
                <italic toggle="yes">f&#x2032;&#x2032;</italic>=4.7e
                <sup>-</sup> at CuK&#x03b1;) comparable to that of iodine, promote crystal growth
                <sup>
                    <xref ref-type="bibr" rid="ref-6">6</xref>
                </sup>, and can substitute other divalent cations in metal-binding proteins. Despite all these advantages and its use in the very early SAD works
                <sup>
                    <xref ref-type="bibr" rid="ref-7">7</xref>
                </sup>, Cd is rarely used in the phasing of protein crystals. Recently, a paper emphasizing the utility of cadmium ions for experimental phasing at the standard synchrotron wavelength of 1 &#x212b; was published
                <sup>
                    <xref ref-type="bibr" rid="ref-8">8</xref>
                </sup>. In this short research note, we show how Cd-SAD can also be conveniently used for phasing datasets collected using CuK&#x03b1; radiation.</p>
        </sec>
        <sec sec-type="methods">
            <title>Methods</title>
            <p>As an experimental model for in-house cadmium SAD, we used a crystal of an anti-ErbB3 single-domain antibody BCD090-M2, which we recently studied
                <sup>
                    <xref ref-type="bibr" rid="ref-9">9</xref>
                </sup>. The details of protein purification, characterization, and structural analysis are given in the paper
                <sup>
                    <xref ref-type="bibr" rid="ref-9">9</xref>
                </sup>. Briefly, the protein was expressed in 
                <italic toggle="yes">E. coli SHuffle</italic> cells as a SUMO fusion, purified by immobilized metal affinity chromatography, cleaved by TEV protease, and then polished by an additional step of high-resolution cation-exchange chromatography. The antibody was crystallized by hanging-drop vapor diffusion in two different forms: in a space group C2 without divalent cations (PDB accession number: 
                <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6EZW">6EZW</ext-link>) and in P1 with two cadmium ions per unit cell (PDB accession number: 
                <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6F0D">6F0D</ext-link>)
                <sup>
                    <xref ref-type="bibr" rid="ref-9">9</xref>
                </sup>. Crystals of both types diffracted below 2 &#x212b;. The data were collected on a Kappa Apex II diffractometer (Bruker AXS) using CuK&#x03b1; radiation generated by a I&#x03bc;S microfocus X-ray tube. Both structures were solved by molecular replacement in 
                <ext-link ext-link-type="uri" xlink:href="https://www.phenix-online.org/">Phenix</ext-link> software suite v. 1.11
                <sup>
                    <xref ref-type="bibr" rid="ref-10">10</xref>
                </sup>. The dataset with cadmium (6F0D) with unmerged Friedel pairs was used for SAD analysis. For experimental phasing, we used a standard protocol employing 
                <italic toggle="yes">SHELXC/D/E</italic> programs
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>
                </sup> through 
                <italic toggle="yes">HKL2MAP</italic> v. 0.4 graphical interface
                <sup>
                    <xref ref-type="bibr" rid="ref-12">12</xref>
                </sup>. Data were processed with 
                <italic toggle="yes">SHELXC</italic> v. 2016/1, anomalous substructure was solved by 
                <italic toggle="yes">SHELXD</italic> v. 2013/2 and phasing and density modification were done by 
                <italic toggle="yes">SHELXE</italic> v. 2018/2. The automatic model building and refinement were done in Phenix v. 1.14
                <sup>
                    <xref ref-type="bibr" rid="ref-10">10</xref>
                </sup>, and manual refinement was done in 
                <italic toggle="yes">Coot</italic> v. 0.8.9.1
                <sup>
                    <xref ref-type="bibr" rid="ref-13">13</xref>
                </sup>. Figures were prepared with 
                <italic toggle="yes">PyMOL</italic>.</p>
        </sec>
        <sec sec-type="results | discussion">
            <title>Results and discussion</title>
            <p>The phasing of protein crystals by SAD starts from finding the positions of an anomalous substructure, which is usually done by direct methods. First, the dataset was processed with 
                <italic toggle="yes">SHELXC</italic>, and the statistical analysis of the anomalous signal is shown in 
                <xref ref-type="fig" rid="f1">Figure 1A</xref> and 
                <xref ref-type="table" rid="T1">Table 1</xref>. The use of kappa goniometer for data collection allowed achieving high completeness (96.4%) and multiplicity (5.9) of anomalous pair measurements. The signal-to-noise ratio defined as &#x27e8;d&#x2032;&#x2032;/&#x03c3;(d&#x2032;&#x2032;)&#x27e9; and the correlation coefficient CC
                <sub>1/2 </sub>indicate that useful anomalous signal is present almost in the whole resolution range. For further substructure solution, we implied a rather conservative high-resolution cut-off of 2.4 &#x212b; corresponding to CC
                <sub>1/2</sub> (anom.) ~ 0.3.</p>
            <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                <label>Figure 1. </label>
                <caption>
                    <title>Cadmium SAD phasing of the dataset collected at CuK&#x03b1; wavelength.</title>
                    <p>The crystal of the single-domain antibody BCD090-M2 with cadmium ions was used as an experimental model for in-house Cd-SAD. (
                        <bold>A</bold>) Strength of the anomalous signal represented by &#x27e8;d&#x2032;&#x2032;/&#x03c3;(d&#x2032;&#x2032;)&#x27e9; and CC
                        <sub>1/2</sub> as a function of resolution. (
                        <bold>B</bold>) Electron density modification in SHELXE as monitored by an increase in map contrast; solutions with original and inverted anomalous substructure give indistinguishable contrast due to centrosymmetry. (
                        <bold>C</bold>) Cadmium ion binding site. (
                        <bold>D</bold>) Schematic representation of the crystal unit cell.</p>
                </caption>
                <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/19346/7cdace7a-d4b2-4d3f-89f6-0e38051ceb80_figure1.gif"/>
            </fig>
            <table-wrap id="T1" orientation="portrait" position="anchor">
                <label>Table 1. </label>
                <caption>
                    <title>Cadmium SAD phasing and model building results.</title>
                    <p>Values in parentheses are for the highest resolution shell.</p>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1">Parameter</th>
                            <th align="left" colspan="1" rowspan="1">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <italic toggle="yes">Dataset statistics (6F0D)</italic>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Space group</td>
                            <td align="left" colspan="1" rowspan="1">P1</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Unit cell: a b c (A&#x030a;) &#x03b1; &#x03b2; &#x03b3; (&#x25e6;)</td>
                            <td align="left" colspan="1" rowspan="1">35.77 41.53 46.49 89.99 67.92 76.06</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Resolution range, A&#x030a;</td>
                            <td align="left" colspan="1" rowspan="1">32.34&#x2013;1.90 (1.94&#x2013;1.90)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Reflections: total / unique</td>
                            <td align="left" colspan="1" rowspan="1">246903 (6236) / 18859 (1265)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Completeness (all), %</td>
                            <td align="left" colspan="1" rowspan="1">100.0 (100.0)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Completeness (anom.), %</td>
                            <td align="left" colspan="1" rowspan="1">96.4 (89.9)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Multiplicity</td>
                            <td align="left" colspan="1" rowspan="1">13.1 (4.9)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Multiplicity (anom.)</td>
                            <td align="left" colspan="1" rowspan="1">5.9 (2.4)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Mean I/&#x03c3;(I)</td>
                            <td align="left" colspan="1" rowspan="1">14.9 (2.2)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <italic toggle="yes">SHELXD</italic>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;Resolution range, A&#x030a;</td>
                            <td align="left" colspan="1" rowspan="1">32.34&#x2013;2.4</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;CFOM</td>
                            <td align="left" colspan="1" rowspan="1">55.61</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;CC
                                <sub>all</sub>/CC
                                <sub>weak</sub>
                            </td>
                            <td align="left" colspan="1" rowspan="1">32.40 / 23.21</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;No. of sites</td>
                            <td align="left" colspan="1" rowspan="1">2/2</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <italic toggle="yes">SHELXE</italic>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;No. of residues built</td>
                            <td align="left" colspan="1" rowspan="1">222 / 256 (87%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;CC</td>
                            <td align="left" colspan="1" rowspan="1">43.57</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <italic toggle="yes">phenix.autobuild</italic>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;No. of residues built</td>
                            <td align="left" colspan="1" rowspan="1">245 / 256 (96%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;CC</td>
                            <td align="left" colspan="1" rowspan="1">0.80</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">
                                <italic toggle="yes">Refinement</italic>
                            </td>
                            <td colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;No. of residues built</td>
                            <td align="left" colspan="1" rowspan="1">256/256 (100%)</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;CC</td>
                            <td align="left" colspan="1" rowspan="1">0.90</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1">&#x00a0;&#x00a0;R
                                <sub>work</sub> / R
                                <sub>free</sub>, %</td>
                            <td align="left" colspan="1" rowspan="1">17.8 / 21.0</td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <fn>
                        <p>CFOM, combined figure of merit; CC, correlation coefficient.</p>
                    </fn>
                </table-wrap-foot>
            </table-wrap>
            <p>	The anomalous substructure was immediately solved by 
                <italic toggle="yes">SHELXD</italic> as judged by high correlation coefficients (combined figure of merit = 55.6%), high occupancies of the two cadmium sites (1.00, 0.99), and the rapid drop in occupancy of the next site (0.17). The positions of Cd ions corresponded to the largest off-origin peak of the anomalous Patterson function at (0.58, 0.02, 0.03). The solution was used in 
                <italic toggle="yes">SHELXE</italic> for phasing, electron density modification, and chain tracing. This yielded electron density maps with high contrast, and the solutions for original and inverted substructure were indistinguishable due to centrosymmetry (
                <xref ref-type="fig" rid="f1">Figure 1B</xref>). As discussed previously
                <sup>
                    <xref ref-type="bibr" rid="ref-14">14</xref>
                </sup>, centrosymmetric anomalous sites in SAD can impede interpretation of electron density maps, because the resulting map is a superposition of the true electron density with its negative mirror-image. However, in our case the major portion of the protein chain (87%) was traced after density modification. This incomplete model was further improved in 
                <italic toggle="yes">phenix.autobuild</italic>, and then refined manually in 
                <italic toggle="yes">Coot</italic> and 
                <italic toggle="yes">phenix.refine</italic> giving final R
                <sub>work</sub>/R
                <sub>free</sub> of 17.8/21.0%.</p>
            <p>	In this particular case, structure determination by in-house Cd-SAD was almost as straightforward as an automated molecular replacement. The causes of this simplicity were the relatively small protein size, high completeness and multiplicity of the anomalous data, and the small number of high-occupancy cadmium sites. Furthermore, the recent theoretical study gives the following simple dependency for expected anomalous signal &#x27e8;S
                <sub>ano</sub>&#x27e9; ~ (N
                <sub>refl</sub>/n
                <sub>sites</sub>)
                <sup>1/2</sup>, where N
                <sub>refl</sub> is the number of independent reflections and n
                <sub>sites</sub> is the number of anomalous scatterers
                <sup>
                    <xref ref-type="bibr" rid="ref-15">15</xref>
                </sup>. Our case with maximum N
                <sub>refl</sub> due to the lowest symmetry (P1) and only 2 anomalous sites appears virtually optimal for SAD. The high metal-binding affinity of cadmium sites was achieved through coordination with carbonyl oxygen of Glu
                <sub>114</sub>, and carboxylic groups of Asp
                <sub>100</sub> and Asp
                <sub>116</sub> (
                <xref ref-type="fig" rid="f1">Figure 1C</xref>). By bridging these residues to the N-terminal Gly residue of the neighboring molecule, cadmium ions effectively defined crystal contacts (
                <xref ref-type="fig" rid="f1">Figure 1D</xref>). Data associated with this study are available on OSF
                <sup>
                    <xref ref-type="bibr" rid="ref-16">16</xref>
                </sup>.</p>
        </sec>
        <sec sec-type="conclusions">
            <title>Conclusion</title>
            <p>In conclusion, we suggest that cadmium SAD can be generally applied for the phasing of protein crystals collected in-house using CuK&#x03b1; radiation. We see the following advantages of this approach: (1) cadmium has a great anomalous signal (
                <italic toggle="yes">f&#x2032;&#x2032;</italic>=4.7e
                <sup>-</sup> at CuK&#x03b1;); (2) cadmium ions frequently promote crystal growth and can substitute other divalent cations; (3) cadmium binding sites are complementary to that of iodine, another strong anomalous scatterer, and therefore Cd-SAD can be useful in cases where I-SAD does not work.</p>
        </sec>
        <sec>
            <title>Data availability</title>
            <p>Data for this study, including unmerged experimental intensities, structure factors and final atomic coordinates after refinement, are available on OSF. DOI: 
                <ext-link ext-link-type="uri" xlink:href="https://dx.doi.org/10.17605/OSF.IO/KYH6D">https://doi.org/10.17605/OSF.IO/KYH6D</ext-link>
                <sup>
                    <xref ref-type="bibr" rid="ref-16">16</xref>
                </sup>.</p>
            <p>Data are available under the terms of the 
                <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons Zero &#x201c;No rights reserved&#x201d; data waiver</ext-link> (CC0 1.0 Public domain dedication).</p>
        </sec>
    </body>
    <back>
        <ref-list>
            <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hendrickson</surname>
                            <given-names>WA</given-names>
                        </name>
</person-group>:
                    <article-title>Anomalous diffraction in crystallographic phase evaluation.</article-title>
                    <source>

                        <italic toggle="yes">Q Rev Biophys.</italic>
</source>
                    <year>2014</year>;<volume>47</volume>(<issue>1</issue>):<fpage>49</fpage>&#x2013;<lpage>93</lpage>.
                    <pub-id pub-id-type="pmid">24726017</pub-id>
                    <pub-id pub-id-type="doi">10.1017/S0033583514000018</pub-id>
                    <pub-id pub-id-type="pmcid">4128195</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hendrickson</surname>
                            <given-names>WA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Teeter</surname>
                            <given-names>MM</given-names>
                        </name>
</person-group>:
                    <article-title>Structure of the hydrophobic protein crambin determined directly from the anomalous scattering of sulphur.</article-title>
                    <source>

                        <italic toggle="yes">Nature.</italic>
</source>
                    <year>1981</year>;<volume>290</volume>(<issue>5802</issue>):<fpage>107</fpage>&#x2013;<lpage>113</lpage>.
                    <pub-id pub-id-type="pmid">28769131</pub-id>
                    <pub-id pub-id-type="doi">10.1038/290107a0</pub-id>
                    <pub-id pub-id-type="pmcid">5536114</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kim</surname>
                            <given-names>MK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>An</surname>
                            <given-names>YJ</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>In-house zinc SAD phasing at Cu K&#x03b1; edge.</article-title>
                    <source>

                        <italic toggle="yes">Mol Cells.</italic>
</source>
                    <year>2013</year>;<volume>36</volume>(<issue>1</issue>):<fpage>74</fpage>&#x2013;<lpage>81</lpage>.
                    <pub-id pub-id-type="pmid">23686432</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10059-013-0074-1</pub-id>
                    <pub-id pub-id-type="pmcid">3887929</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Abendroth</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gardberg</surname>
                            <given-names>AS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Robinson</surname>
                            <given-names>JI</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SAD phasing using iodide ions in a high-throughput structural genomics environment.</article-title>
                    <source>

                        <italic toggle="yes">J Struct Funct Genomics.</italic>
</source>
                    <year>2011</year>;<volume>12</volume>(<issue>2</issue>):<fpage>83</fpage>&#x2013;<lpage>95</lpage>.
                    <pub-id pub-id-type="pmid">21359836</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10969-011-9101-7</pub-id>
                    <pub-id pub-id-type="pmcid">3123459</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Melnikov</surname>
                            <given-names>I</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Polovinkin</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kovalev</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Fast iodide-SAD phasing for high-throughput membrane protein structure determination.</article-title>
                    <source>

                        <italic toggle="yes">Sci Adv.</italic>
</source>
                    <year>2017</year>;<volume>3</volume>(<issue>5</issue>):<fpage>e1602952</fpage>.
                    <pub-id pub-id-type="pmid">28508075</pub-id>
                    <pub-id pub-id-type="doi">10.1126/sciadv.1602952</pub-id>
                    <pub-id pub-id-type="pmcid">5429034</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Trakhanov</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kreimer</surname>
                            <given-names>DI</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Parkin</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Cadmium-induced crystallization of proteins: II. Crystallization of the Salmonella typhimurium histidine-binding protein in complex with L-histidine, L-arginine, or L-lysine.</article-title>
                    <source>

                        <italic toggle="yes">Protein Sci.</italic>
</source>
                    <year>1998</year>;<volume>7</volume>(<issue>3</issue>):<fpage>600</fpage>&#x2013;<lpage>604</lpage>.
                    <pub-id pub-id-type="pmid">9541391</pub-id>
                    <pub-id pub-id-type="doi">10.1002/pro.5560070308</pub-id>
                    <pub-id pub-id-type="pmcid">2143943</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Robbins</surname>
                            <given-names>AH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McRee</surname>
                            <given-names>DE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Williamson</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Refined crystal structure of Cd, Zn metallothionein at 2.0 A resolution.</article-title>
                    <source>

                        <italic toggle="yes">J Mol Biol.</italic>
</source>
                    <year>1991</year>;<volume>221</volume>(<issue>4</issue>):<fpage>1269</fpage>&#x2013;<lpage>1293</lpage>.
                    <pub-id pub-id-type="pmid">1942051</pub-id>
                    <pub-id pub-id-type="doi">10.1016/0022-2836(91)90933-W</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Panneerselvam</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kumpula</surname>
                            <given-names>EP</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kursula</surname>
                            <given-names>I</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Rapid cadmium SAD phasing at the standard wavelength (1&#x2005;&#x00c5;).</article-title>
                    <source>

                        <italic toggle="yes">Acta Crystallogr D Struct Biol.</italic>
</source>
                    <year>2017</year>;<volume>73</volume>(<issue>Pt 7</issue>):<fpage>581</fpage>&#x2013;<lpage>590</lpage>.
                    <pub-id pub-id-type="pmid">28695858</pub-id>
                    <pub-id pub-id-type="doi">10.1107/S2059798317006970</pub-id>
                    <pub-id pub-id-type="pmcid">5505155</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Eliseev</surname>
                            <given-names>IE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Yudenko</surname>
                            <given-names>AN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vysochinskaya</surname>
                            <given-names>VV</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor [version 2; referees: 2 approved].</article-title>
                    <source>

                        <italic toggle="yes">F1000Res.</italic>
</source>
                    <year>2018</year>;<volume>7</volume>:<fpage>57</fpage>.
                    <pub-id pub-id-type="pmid">30430004</pub-id>
                    <pub-id pub-id-type="doi">10.12688/f1000research.13612.2</pub-id>
                    <pub-id pub-id-type="pmcid">6097396</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Adams</surname>
                            <given-names>PD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Afonine</surname>
                            <given-names>PV</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bunk&#x00f3;czi</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>
                        <italic toggle="yes">PHENIX</italic>: a comprehensive Python-based system for macromolecular structure solution.</article-title>
                    <source>

                        <italic toggle="yes">Acta Crystallogr D Biol Crystallogr.</italic>
</source>
                    <year>2010</year>;<volume>66</volume>(<issue>Pt 2</issue>):<fpage>213</fpage>&#x2013;<lpage>221</lpage>.
                    <pub-id pub-id-type="pmid">20124702</pub-id>
                    <pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id>
                    <pub-id pub-id-type="pmcid">2815670</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sheldrick</surname>
                            <given-names>GM</given-names>
                        </name>
</person-group>:
                    <article-title>Experimental phasing with 
                        <italic toggle="yes">SHELXC/D/E</italic>: combining chain tracing with density modification.</article-title>
                    <source>

                        <italic toggle="yes">Acta Crystallogr D Biol Crystallogr.</italic>
</source>
                    <year>2010</year>;<volume>66</volume>(<issue>Pt 4</issue>):<fpage>479</fpage>&#x2013;<lpage>485</lpage>.
                    <pub-id pub-id-type="pmid">20383001</pub-id>
                    <pub-id pub-id-type="doi">10.1107/S0907444909038360</pub-id>
                    <pub-id pub-id-type="pmcid">2852312</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pape</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schneider</surname>
                            <given-names>TR</given-names>
                        </name>
</person-group>:
                    <article-title>
                        <italic toggle="yes">HKL2MAP</italic>: a graphical user interface for macromolecular phasing with 
                        <italic toggle="yes">SHELX</italic> programs.</article-title>
                    <source>

                        <italic toggle="yes">J Appl Crystallogr.</italic>
</source>
                    <year>2004</year>;<volume>37</volume>(<issue>5</issue>):<fpage>843</fpage>&#x2013;<lpage>844</lpage>.
                    <pub-id pub-id-type="doi">10.1107/S0021889804018047</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Emsley</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lohkamp</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Scott</surname>
                            <given-names>WG</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Features and development of 
                        <italic toggle="yes">Coot</italic>.</article-title>
                    <source>

                        <italic toggle="yes">Acta Crystallogr D Biol Crystallogr.</italic>
</source>
                    <year>2010</year>;<volume>66</volume>(<issue>Pt 4</issue>):<fpage>486</fpage>&#x2013;<lpage>501</lpage>.
                    <pub-id pub-id-type="pmid">20383002</pub-id>
                    <pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>
                    <pub-id pub-id-type="pmcid">2852313</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>McCoy</surname>
                            <given-names>AJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Read</surname>
                            <given-names>RJ</given-names>
                        </name>
</person-group>:
                    <article-title>Experimental phasing: best practice and pitfalls.</article-title>
                    <source>

                        <italic toggle="yes">Acta Crystallogr D Biol Crystallogr.</italic>
</source>
                    <year>2010</year>;<volume>66</volume>(<issue>Pt 4</issue>):<fpage>458</fpage>&#x2013;<lpage>469</lpage>.
                    <pub-id pub-id-type="pmid">20382999</pub-id>
                    <pub-id pub-id-type="doi">10.1107/S0907444910006335</pub-id>
                    <pub-id pub-id-type="pmcid">2852310</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Terwilliger</surname>
                            <given-names>TC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bunk&#x00f3;czi</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hung</surname>
                            <given-names>LW</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Can I solve my structure by SAD phasing? Anomalous signal in SAD phasing.</article-title>
                    <source>

                        <italic toggle="yes">Acta Crystallogr D Struct Biol.</italic>
</source>
                    <year>2016</year>;<volume>72</volume>(<issue>Pt 3</issue>):<fpage>346</fpage>&#x2013;<lpage>358</lpage>.
                    <pub-id pub-id-type="pmid">26960122</pub-id>
                    <pub-id pub-id-type="doi">10.1107/S2059798315019269</pub-id>
                    <pub-id pub-id-type="pmcid">4784666</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Eliseev</surname>
                            <given-names>I</given-names>
                        </name>
</person-group>:
                    <article-title>Cadmium SAD phasing at CuK&#x03b1; wavelength.</article-title>
                    <source>

                        <italic toggle="yes">OSF.</italic>
</source>
                    <year>2019</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.doi.org/10.17605/OSF.IO/KYH6D">http://www.doi.org/10.17605/OSF.IO/KYH6D</ext-link>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report45676">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.19346.r45676</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Melnikov</surname>
                        <given-names>Igor</given-names>
                    </name>
                    <xref ref-type="aff" rid="r45676a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-2265-4534</uri>
                </contrib>
                <aff id="r45676a1">
                    <label>1</label>European Synchrotron Radiation Facility (ESRF), Grenoble, France</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>1</day>
                <month>4</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Melnikov I</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport45676" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.17694.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>In this experiment report the authors present their work on derivatising crystals of a single-domain antibody protein with cadmium ions and subsequent solving the structure via SAD. They demonstrate that home-lab X-ray crystallographic&#x00a0;equipment is capable of solving crystal structures via SAD at CuKalpha X-ray energy.&#x00a0;The authors then conclude by discussing the result and suggesting the method for use in home-lab source diffraction experiments. To sum up, I find&#x00a0;the study to be clearly presented and well&#x00a0;prepared.</p>
            <p> </p>
            <p> Additional notes: 
                <list list-type="bullet">
                    <list-item>
                        <p>To my point of view, the data were collected competently to reach higher multiplicity&#x00a0;(which&#x00a0;is indispensable for SAD phasing) for P1 space group by&#x00a0;exploiting kappa goniometer.</p>
                    </list-item>
                    <list-item>
                        <p>The workflow for structure solution via Cd-SAD&#x00a0;presented in this article seems to be relatively straightforward even considering the problem with centrosymmetric Cd sites (easily resolved by chain tracing).</p>
                    </list-item>
                    <list-item>
                        <p>"The phasing of protein crystals by SAD starts from finding the positions of an anomalous substructure, which is usually done by direct methods." - In fact, the process involves Patterson search coupled with direct methods-based calculations
                            <sup>
                                <xref ref-type="bibr" rid="rep-ref-45676-1">1</xref>
                            </sup>&#x00a0;namely dual-space refinement.</p>
                    </list-item>
                    <list-item>
                        <p>I might suggest adding a few words on how the authors introduced cadmium ions into the crystal (I see&#x00a0;that it was&#x00a0;co-crystallisation as reported in their previous article).</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Not applicable</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Macromolecular crystallography, structural biology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-45676-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Substructure solution withSHELXD</article-title>.
                        <source>
                            <italic>Acta Crystallographica Section D Biological Crystallography</italic>
                        </source>.<year>2002</year>;<volume>58</volume>(<issue>10</issue>) :
                        <elocation-id>10.1107/S0907444902011678</elocation-id>
                        <fpage>1772</fpage>-<lpage>1779</lpage>
                        <pub-id pub-id-type="doi">10.1107/S0907444902011678</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report43346">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.19346.r43346</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Edwards</surname>
                        <given-names>Thomas E.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r43346a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r43346a1">
                    <label>1</label>Bainbridge Island, Bainbridge Island, WA, 98110, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>18</day>
                <month>2</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Edwards TE</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport43346" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.17694.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Eliseev et al. demonstrate the ability to use cadmium divalent cations, X-ray data collected on an in house X-ray source (Cu Kalpha),&#x00a0;and single wavelength anomalous dispersion (SAD) phasing to determine the structure of a protein, in this case the anti-ErbB3 single domain antibody (sdAb). They originally solved the structure by molecular replacement (MR) and reported it in a previous publication, but here they demonstrate the applicability of Cd-SAD to this data set to determine the structure. By our examination of the literature, at least two other structures have been solved by Cd-SAD but both of these structures were solved using data collected at a synchrotron source at a longer wavelength (PDB IDs 2X7K and 5AM6). This particular application provides an excellent alternative method to others presented in the literature and referenced in this paper.</p>
            <p> A couple of notes and comments: 
                <list list-type="order">
                    <list-item>
                        <p>The authors may help the reader understand the number of electron possible for phasing by referring the reader to the UW X-ray anomalous scattering web page (http://skuld.bmsc.washington.edu/scatter/) designed by Ethan Merritt.</p>
                    </list-item>
                    <list-item>
                        <p>The authors do an excellent job of data collection on their in house instrument by using the kappa goniometer to increase completeness and enhance the anomalous signal.</p>
                    </list-item>
                    <list-item>
                        <p>The authors should also site a second paper by Terwilliger et al. from the same issue as reference 15 but with pages 359-374
                            <sup>
                                <xref ref-type="bibr" rid="rep-ref-43346-1">1</xref>
                            </sup> which provides additional information on experimental design and execution.</p>
                    </list-item>
                    <list-item>
                        <p>We performed an overnight soak at 5 mM CdCl2, collected a high resolution data set in house on a Cu Kalpha source, and obtained sufficient anomalous signal to solve the structure by Cd-SAD. This provided us with good confidence that this method&#x00a0;should be generally applicable.&#x00a0;</p>
                    </list-item>
                </list> Overall, the current paper by Eliseev provides a good alternative approach to experimental structure determination, complementing previously reported techniques.</p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Not applicable</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>X-ray crystallography, small molecular and antibody therapeutic development, de novo phasing.</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-43346-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Can I solve my structure by SAD phasing? Planning an experiment, scaling data and evaluating the useful anomalous correlation and anomalous signal.</article-title>
                        <source>
                            <italic>Acta Crystallogr D Struct Biol</italic>
                        </source>.<year>2016</year>;<volume>72</volume>(<issue>Pt 3</issue>) :
                        <elocation-id>10.1107/S2059798315019403</elocation-id>
                        <fpage>359</fpage>-<lpage>74</lpage>
                        <pub-id pub-id-type="pmid">26960123</pub-id>
                        <pub-id pub-id-type="doi">10.1107/S2059798315019403</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
</article>
